Successful treatment of palmar-Successful treatment of palmar-Successful treatment of palmar-Successful treatment of palmar-Successful treatment of palmarplantar erythrodysesthesia plantar erythrodysesthesia plantar erythrodysesthesia plantar erythrodysesthesia plantar erythrodysesthesia possibly due to temozolomide with possibly due to temozolomide with possibly due to temozolomide with possibly due to temozolomide with possibly due to temozolomide with dexamethasone dexamethasone dexamethasone dexamethasone dexamethasone
Sir, Palmar-plantar erythrodysesthesia (PPE) is a cutaneous toxicity administered. Thus, the PPE was attributed to temozolomide. He was treated with intravenous dexamethasone at a dose of 32 mg/d for seven days. As the skin lesions resolved with brownish discoloration, this therapy was tapered over the following one week. The chemotherapy regimen of the patient had to be ceased because of the rapid progression in the clinical course.
In this patient, temozolomide-induced PPE might be caused by a cumulative toxic effect on the skin, since PPE occurred after fifth cycle of therapy. The patient received a combination of temozolomide and phenytoin, thus it is difficult to decide which drug or their combination is responsible for the skin of some chemotherapeutic agents such as 5-FU, doxorubicine and capecitabine. [1, 2] Clinicians could also encounter this lesions. However, as suggested by the patient's history and available data in literature, it is most likely that the skin reaction reaction in response to treatment with novel agents.
was induced by temozolomide. Temozolomide is a new alkylating agent that has demonstrated promising activity in the treatment of primary or metastatic brain tumors. [3] Herein, we present a case of PPE possibly due
We treated our patient with intravenous dexamethasone and his symptoms and signs disappeared within one week. The to temozolomide therapy.
prompt improvement of skin lesions as compared with the normal course of the disease (five to six weeks) confirmed the A 67-year-old man presented with headache caused by a large efficiency of dexamethasone therapy previously reported. [1] intracerebral frontal tumor. The tumor was totally resected and a diagnosis of glioblastoma multiforme was established.
In conclusion, chemotherapy-induced PPE is a fascinating Following the surgery, he received radiation therapy. Three clinical problem that can occur when using new and months later, locally tumor recurrence was detected and temozolomide was started at a dose of 200 mg/m 2 for five days investigational agents as in this patient. We conclude that the patient is possibly a case of PPE to temozolomide. Therefore, every four weeks. A stable disease was achieved. Following the we suggest that clinicians should be aware of the potential for completion of the fifth cycle, the patient complained of a burning PPE in patients receiving temozolomide. sensation at the lateral edges of hands and feet. References dilated blood vessels and perivascular lymphocytic infiltration. The patient's only concurrent medications were multivitamins
